Show/hide main menu

FODMAPs

Research

Meet the FODMAP team:

 

narrow-page-divide-sea-greenResearch publications:

So D, Whelan K, Rossi M, Morrison M, Holtmann G, Kelly JT, Shanahan ER, Staudacher HM, Campbell KL. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr. 2018; 107: 965-983.

https://academic.oup.com/ajcn/article-lookup/doi/10.1093/ajcn/nqy041

 

Staudacher HM, Kurien M, Whelan K. Nutritional implications of dietary interventions for managing gastrointestinal disorders. Curr Opin Gastro. 2018; 34: 105–111.

https://insights.ovid.com/pubmed?pmid=29278531

 

Healey G, Murphy R, Butts C, Brough L, Whelan K, Coad J. Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study. Brit J Nutr. 2018; 119: 176-189.

https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/habitual-dietary-fibre-intake-influences-gut-microbiota-response-to-an-inulintype-fructan-prebiotic-a-randomised-doubleblind-placebocontrolled-crossover-human-intervention-study/637C3E930108F079BD8DB4049562449C

 

Lever E, Scott SM, Louis P, Emery PW, Whelan K. The effect of prunes on stool output, gut transit time and gastrointestinal microbiota: a randomised controlled trial. Clin Nutr. 2018 (in press).

https://www.sciencedirect.com/science/article/pii/S0261561418300037?via%3Dihub

 

Whelan K, Martin LD, Staudacher HM, Lomer MC. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet. 2018; 31: 239-255.

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jhn.12530/abstract

 

Rossi M, Aggio R, Staudacher HM, Lomer MC, Lindsay JO, Irving PM, Probert C, Whelan K. Volatile organic compounds in feces associate with response to dietary intervention in patients with irritable bowel syndrome. Clin Gastro Hep 2018; 16: 385-391.

https://www.sciencedirect.com/science/article/pii/S1542356517312016?via%3Dihub

 

Dimidi E, Rossi M, Whelan K. Irritable bowel syndrome and diet: where are we in 2018? Current Opinion Clinical Nutr Metab 2017; 20: 456-463.

https://insights.ovid.com/pubmed?pmid=28872467

 

Staudacher HM, Lomer MCE, Farquharson FM, Louis P, Fava F, Franciosi E, Scholz M, Tuohy KM, Lindsay JO, Irving PM, Whelan K. Diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and probiotic restores bifidobacterium species: a randomized controlled trial. Gastroenterology. 2017; 153: 936–947.

https://www.sciencedirect.com/science/article/pii/S001650851735744X

 

Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in irritable bowel syndrome. Gut. 2017; 66: 1517-1527. 

http://gut.bmj.com/content/66/8/1517.long

 

Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, Whelan K. Fermentable carbohydrates (FODMAPs) exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial. J Crohns Colitis. 2017; 11: 1420-1429.

https://academic.oup.com/ecco-jcc/article/11/12/1420/3835798

 

Prince A, Myers CM, Joyce T, Irving PM, Lomer MC, Whelan K. Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm Bowel Disease. 2016; 22: 1129-1136.

https://academic.oup.com/ibdjournal/article-abstract/22/5/1129/4561787

 

Staudacher HM, Whelan K. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. Proc Nutr Soc. 2016; 75: 306-18.

https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/altered-gastrointestinal-microbiota-in-irritable-bowel-syndrome-and-its-modification-by-diet-probiotics-prebiotics-and-the-low-fodmap-diet/8A7E00D44BD17B2F192D8EEBE464AD03

 

Whigham L, Joyce T, Harper G, Irving PM, Staudacher HM, Whelan K, Lomer MC. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J Hum Nutr Diet. 2015; 28: 687–696.

http://onlinelibrary.wiley.com/doi/10.1111/jhn.12318/abstract;jsessionid=4A829E182C549618033ADBE57DBBD8DD.f02t01 

 

Anderson JL, Hedin CR, Benjamin JL, Koutsoumpas A, Ng SC, Hart AL, Forbes AF, Stagg AJ, Lindsay JO, Whelan K. Dietary intake of inulin-type fructans in active and inactive Crohn’s disease and healthy controls: a case-control study. J Crohn’s Colitis. 2015; 9: 1024-31.

https://academic.oup.com/ecco-jcc/article/9/11/1024/404546

 

Staudacher HM, Irving PM, Lomer MC, Whelan K. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nature Gastro Hep. 2014; 11: 256-266.

https://www.nature.com/articles/nrgastro.2013.259

 

Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014; 100: 1075–84.

https://academic.oup.com/ajcn/article/100/4/1075/4576460

 

Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM, Whelan K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012; 142: 1510-8.

https://academic.oup.com/jn/article/142/8/1510/4630946

 

Staudacher H, Whelan K, Irving P, Lomer MCE. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet. 2011; 24: 487-495.

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-277X.2011.01162.x/abstract

 

 

Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2019 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454